Article ID Journal Published Year Pages File Type
8229070 International Journal of Radiation Oncology*Biology*Physics 2011 7 Pages PDF
Abstract
Concomitant boost to areas showing increased uptake in 111In-capromab pendetide scan to 82 Gy using intensity-modulated radiotherapy while the entire prostate received 75.6 Gy was feasible and tolerable, with 94% biochemical control rate at 5 years.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Image-Guided Radiotherapy for Prostate Cancer: A Prospective Trial of Concomitant Boost Using Indium-111-Capromab Pendetide (ProstaScint) Imaging
Authors
, , , , , , ,